{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-056432","form_type":"8-K","ticker":"SEM","cik":"0001320414","company_name":"SELECT MEDICAL HOLDINGS CORP","filed_at":"2024-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.826584+00:00","generated_at":"2026-06-03T00:08:06.852339+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Select Medical reports Q1 2024 revenue $1.79B (+7.4%), adj EPS $0.77 (+37.5%); declares $0.125 dividend; updates outlook","bullets":["Revenue $1,788.8M (+7.4% YoY); net income $117.2M (+37.4%); GAAP EPS $0.75 (+33.9%).","Adjusted EPS $0.77 (+37.5% YoY); Adjusted EBITDA $261.9M (+22.4% YoY).","Critical illness recovery hospital segment adjusted EBITDA $115.9M (+51.0%); margin improved to 17.7%.","Reaffirms 2024 revenue outlook $6.9-7.1B; adjusts EBITDA outlook to $845-885M; adj EPS outlook $1.96-2.20.","Declares cash dividend $0.125 per share, payable May 30, 2024 to holders of record May 16."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-056432","json":"https://secwatch.observer/filing/0001104659-24-056432.json","markdown":"https://secwatch.observer/filing/0001104659-24-056432.md","text":"https://secwatch.observer/filing/0001104659-24-056432.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1320414/000110465924056432/0001104659-24-056432-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1320414/000110465924056432/tm2413286d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T00:08:06.852339+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b15d25974a312f66312ed61dd82f452d4960531e","claim":"SELECT MEDICAL HOLDINGS CORP reported for its first quarter ended March 31, 2024 results: revenue increased 7.4% to $1,788.8 million, net income increased 37.4% to $117.2 million, EPS increased 33.9% to $0.75.","evidence_excerpt":"SEM) today announced results for its first quarter ended March 31, 2024, and the declaration of a cash dividend. For the first quarter ended March 31, 2024, revenue increased 7.4% to $1,788.8 million, compared to $1,665.0 million for the same quarter, prior year. Income from operations increased 28.1% to $194.0 million for the first quarter ended March","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1320414/000110465924056432/0001104659-24-056432-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"for its first quarter ended March 31, 2024"},{"label":"Revenue","value":"increased 7.4% to $1,788.8 million"},{"label":"Net income","value":"increased 37.4% to $117.2 million"},{"label":"EPS","value":"increased 33.9% to $0.75"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}